V

Vaishali Pharma

(NSE: VAISHALI)

VAISHALI

93.5

0.00 (0.00%)

Vaishali Pharma Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Vaishali Pharma Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Vaishali Pharma Price Summary

Today High

99.85

Today Low

95

52 Week High

99.85

52 Week Low

95

Vaishali Pharma Fundamentals

Market Cap

91.6 Cr

CASA

0.0

No. Of Shares

1.1 Cr

P/E

32.9

P/B

1.5

Face Value

10.0

Dividend Yeild

0.0

Book Value

21.3

Net Interest Income

9.24 L

Cost to Income

NA

Promoter Holdings

26.7

EPS

1.0

CAR

NA

ROE

4.8

ROCE

10.3

Profit Growth

NA

Vaishali Pharma Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Mirae Asset NYSE FANG+ ETF

39.21

NA

NA

NA

NA

NA

NA

NA

Nippon India ETF Infra BEES

513.27

NA

NA

NA

NA

NA

NA

NA

Nifty Bank

0

NA

NA

NA

NA

NA

NA

NA

BHARAT 22 ETF - ICICI Prudential AMC

51.67

NA

NA

NA

NA

NA

NA

NA

Tata Asset Management Ltd. - (NPBET)

201.31

NA

NA

NA

NA

NA

NA

NA

Nippon India ETF Gold BEES

42.45

NA

NA

NA

NA

NA

NA

NA

FAQ’s on Vaishali Pharma

About Vaishali Pharma

The company was incorporated on April 25, 2008 under the provisions of the Companies Act, 1956 as ‘Vaishali Pharma Private Limited’ at Mumbai, Maharashtra. The company acquired the business of M/s. Vaishali Pharmachem which was the proprietorship concern of its Promoter Atul Vasani vide Business Assignment Agreement dated July 01, 2008. It started with trading and marketing of APIs and further in the year 2012, it ventured into marketing of pharmaceuticals formulations, the manufacturing of which is outsourced by it to third parties. The company was converted into Public Company in the year 2017 and the name of the company was changed to ‘Vaishali Pharma Limited’. The company’s registered office is situated at Mumbai and warehousing facilities of the company is located at Bhiwandi, Maharashtra and Vapi, Gujarat.

The company has obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive 93/42/EEC as amended 2007/47/EC relating to Surgical Instruments & Medical Devices Directive. It has received Credit Rating Certification from NSIC CRLS1L for the year 2017-18 as well. The company has also been recognized by Government of India as a ‘One Star Export House’ and holds a valid certificate for the same from the Director General of Foreign Trade.

Business area of the company

The company is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For its export markets, the company gets the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, it has applied for 186 registrations in 13 countries for some of its products, out of which it has successfully received 71 approvals from 7 countries and is in process of obtaining remaining approvals, which will give boost to its export business operations.

Trade Vaishali Pharma today

Create a free portfolio in Trinkerr and earn and grow along with peers